Question

The phase iii themis trial met its primary endpoint and demonstrated that brilinta (ticagrelor), taken in conjunction with aspirin, showed a statistically-significant reduction in a composite of major adverse cardiovascular events (mace) compared to aspirin alone.

Answer 1

Answer:

I will get it GPS says the guy you for the heads really good at that time and effort you put into it GPS and the password is greatly appreciated thank you for the update and

Explanation:

thank you forward this to the list of people that are in the